These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26111625)

  • 1. Meta-analysis of Liver Resection Versus Nonsurgical Treatments for Pancreatic Neuroendocrine Tumors with Liver Metastases.
    Yuan CH; Wang J; Xiu DR; Tao M; Ma ZL; Jiang B; Li ZF; Li L; Wang L; Wang H; Zhang TL
    Ann Surg Oncol; 2016 Jan; 23(1):244-9. PubMed ID: 26111625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of resection of the primary pancreatic neuroendocrine tumor in the multidisciplinary treatment of patients with unresectable synchronous liver metastases: a case series.
    Kondo NI; Ikeda Y; Maehara S; Sugimoto R; Nishiyama K; Sakaguchi Y
    JOP; 2013 Jul; 14(4):415-22. PubMed ID: 23846939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical management of advanced pancreatic neuroendocrine tumors: short-term and long-term results from an international multi-institutional study.
    Birnbaum DJ; Turrini O; Vigano L; Russolillo N; Autret A; Moutardier V; Capussotti L; Le Treut YP; Delpero JR; Hardwigsen J
    Ann Surg Oncol; 2015 Mar; 22(3):1000-7. PubMed ID: 25190116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival prognostic factors of gastro-enteric-pancreatic neuroendocrine tumors after primary tumor resection in a single tertiary center: Comparison of gastro-enteric and pancreatic locations.
    Russolillo N; Vigano' L; Razzore P; Langella S; Motta M; Bertuzzo F; Papotti M; Ferrero A
    Eur J Surg Oncol; 2015 Jun; 41(6):751-7. PubMed ID: 25887286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the role of primary tumour resection in patients with synchronous unresectable liver metastases from pancreatic neuroendocrine tumour of the body and tail. A propensity score survival evaluation.
    Bertani E; Fazio N; Radice D; Zardini C; Spinoglio G; Chiappa A; Ribero D; Biffi R; Partelli S; Falconi M
    Eur J Surg Oncol; 2017 Feb; 43(2):372-379. PubMed ID: 27742480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resection of the primary pancreatic neuroendocrine tumor in patients with unresectable liver metastases: possible indications for a multimodal approach.
    Bertani E; Fazio N; Botteri E; Chiappa A; Falconi M; Grana C; Bodei L; Papis D; Spada F; Bazolli B; Andreoni B
    Surgery; 2014 Apr; 155(4):607-14. PubMed ID: 24582492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of pancreatic neuroendocrine tumors.
    Dickson PV; Behrman SW
    Surg Clin North Am; 2013 Jun; 93(3):675-91. PubMed ID: 23632152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synchronous resection of primary and liver metastases for neuroendocrine tumors.
    Gaujoux S; Gonen M; Tang L; Klimstra D; Brennan MF; D'Angelica M; Dematteo R; Allen PJ; Jarnagin W; Fong Y
    Ann Surg Oncol; 2012 Dec; 19(13):4270-7. PubMed ID: 22752376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of surgical resection for pancreatic neuroendocrine tumors.
    Doi R
    J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):610-7. PubMed ID: 25773163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of resection of the primary pancreatic neuroendocrine tumour only in patients with unresectable metastatic liver disease: a systematic review.
    Capurso G; Bettini R; Rinzivillo M; Boninsegna L; Delle Fave G; Falconi M
    Neuroendocrinology; 2011; 93(4):223-9. PubMed ID: 21358176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidisciplinary management of nonfunctional neuroendocrine tumor of the pancreas.
    Folkert IW; Hernandez P; Roses RE
    World J Gastroenterol; 2016 Mar; 22(11):3105-16. PubMed ID: 27003988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic neuroendocrine metastases: does intervention alter outcomes?
    Chamberlain RS; Canes D; Brown KT; Saltz L; Jarnagin W; Fong Y; Blumgart LH
    J Am Coll Surg; 2000 Apr; 190(4):432-45. PubMed ID: 10757381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic neuroendocrine tumor: A multivariate analysis of factors influencing survival.
    Birnbaum DJ; Turrini O; Ewald J; Barbier L; Autret A; Hardwigsen J; Brunet C; Moutardier V; Le Treut YP; Delpero JR
    Eur J Surg Oncol; 2014 Nov; 40(11):1564-71. PubMed ID: 25086992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose surgical resection of hepatic metastases bring benefits to pancreatic ductal adenocarcinoma? A systematic review and meta-analysis.
    Yu X; Gu J; Fu D; Jin C
    Int J Surg; 2017 Dec; 48():149-154. PubMed ID: 29081375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment strategies of pancreatic neuroendocrine neoplasms with liver metastases].
    Ren SQ; Chen Q; Yuan CH
    Zhonghua Wai Ke Za Zhi; 2020 Jul; 58(7):499-504. PubMed ID: 32610418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resection of Liver Metastases: A Treatment Provides a Long-Term Survival Benefit for Patients with Advanced Pancreatic Neuroendocrine Tumors:
    Yu X; Gu J; Wu H; Fu D; Li J; Jin C
    J Oncol; 2018; 2018():6273947. PubMed ID: 30538745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The First Case Report of Robotic Multivisceral Resection for Synchronous Liver Metastasis from Pancreatic Neuroendocrine Tumor: A Case Report and Literature Review.
    Calin ML; Sadiq A; Arevalo G; Fuentes R; Flanders VL; Gupta N; Nasri B; Singh K
    J Laparoendosc Adv Surg Tech A; 2016 Oct; 26(10):816-824. PubMed ID: 27454160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Nationwide Population-Based Study on the Survival of Patients with Pancreatic Neuroendocrine Tumors in The Netherlands.
    Genc CG; Klümpen HJ; van Oijen MGH; van Eijck CHJ; Nieveen van Dijkum EJM
    World J Surg; 2018 Feb; 42(2):490-497. PubMed ID: 29018912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggressive surgical resection in the management of pancreatic neuroendocrine tumors: when is it indicated?
    Hodul PJ; Strosberg JR; Kvols LK
    Cancer Control; 2008 Oct; 15(4):314-21. PubMed ID: 18813199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.